| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $9.2M | +100.3% |
| SG&A Expense | $14.0M | +65.7% |
| Operating Income | -$23.2M | -77.9% |
| Pre-tax Income | -$19.6M | -66.1% |
| Income Tax | $0 | — |
| Net Income | -$19.6M | -66.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $202.6M | +402.5% |
| Total Assets | $203.8M | +397.7% |
| Current Liabilities | $847K | +99.6% |
| Stockholders' Equity | $203.0M | +400.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.3M | -50.4% |
| Investing Cash Flow | -$11K | — |
| Financing Cash Flow | $176.2M | +743.4% |